220 related articles for article (PubMed ID: 10022458)
1. Discordant measures of androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively.
Shkolny DL; Beitel LK; Ginsberg J; Pekeles G; Arbour L; Pinsky L; Trifiro MA
J Clin Endocrinol Metab; 1999 Feb; 84(2):805-10. PubMed ID: 10022458
[TBL] [Abstract][Full Text] [Related]
2. The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.
Ghali SA; Gottlieb B; Lumbroso R; Beitel LK; Elhaji Y; Wu J; Pinsky L; Trifiro MA
J Clin Endocrinol Metab; 2003 May; 88(5):2185-93. PubMed ID: 12727974
[TBL] [Abstract][Full Text] [Related]
3. Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotypes.
Kazemi-Esfarjani P; Beitel LK; Trifiro M; Kaufman M; Rennie P; Sheppard P; Matusik R; Pinsky L
Mol Endocrinol; 1993 Jan; 7(1):37-46. PubMed ID: 8446106
[TBL] [Abstract][Full Text] [Related]
4. Characterization of normal and point-mutated human androgen receptors expressed in the baculovirus system.
Beitel LK; Sabbaghian N; Alarifi A; Alvarado C; Pinsky L; Trifiro M
J Mol Endocrinol; 1995 Oct; 15(2):117-28. PubMed ID: 8800637
[TBL] [Abstract][Full Text] [Related]
5. A naturally occurring mutation in the human androgen receptor of a subject with complete androgen insensitivity confers binding and transactivation by estradiol.
Bonagura TW; Deng M; Brown TR
Mol Cell Endocrinol; 2007 Jan; 263(1-2):79-89. PubMed ID: 17011702
[TBL] [Abstract][Full Text] [Related]
6. Partial androgen resistance due to a distinctive qualitative defect of the androgen receptor.
Pinsky L; Kaufman M; Levitsky LL
Am J Med Genet; 1987 Jun; 27(2):459-66. PubMed ID: 3605226
[TBL] [Abstract][Full Text] [Related]
7. An examination of how different mutations at arginine 855 of the androgen receptor result in different androgen insensitivity phenotypes.
Elhaji YA; Wu JH; Gottlieb B; Beitel LK; Alvarado C; Batist G; Trifiro MA
Mol Endocrinol; 2004 Aug; 18(8):1876-86. PubMed ID: 15118070
[TBL] [Abstract][Full Text] [Related]
8. Amino acid substitutions in the hormone-binding domain of the human androgen receptor alter the stability of the hormone receptor complex.
Marcelli M; Zoppi S; Wilson CM; Griffin JE; McPhaul MJ
J Clin Invest; 1994 Oct; 94(4):1642-50. PubMed ID: 7929841
[TBL] [Abstract][Full Text] [Related]
9. Human androgen insensitivity due to point mutations encoding amino acid substitutions in the androgen receptor steroid-binding domain.
Murono K; Mendonca BB; Arnhold IJ; Rigon AC; Migeon CJ; Brown TR
Hum Mutat; 1995; 6(2):152-62. PubMed ID: 7581399
[TBL] [Abstract][Full Text] [Related]
10. Response to treatment in patients with partial androgen insensitivity due to mutations in the DNA-binding domain of the androgen receptor.
Lundberg Giwercman Y; Nikoshkov A; Lindsten K; Byström B; Pousette A; Knudtzon J; Alm J; Wedell A
Horm Res; 2000; 53(2):83-8. PubMed ID: 10971094
[TBL] [Abstract][Full Text] [Related]
11. Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.
Yong EL; Tut TG; Ghadessy FJ; Prins G; Ratnam SS
Mol Cell Endocrinol; 1998 Feb; 137(1):41-50. PubMed ID: 9607727
[TBL] [Abstract][Full Text] [Related]
12. Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly-->Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels.
Choong CS; Sturm MJ; Strophair JA; McCulloch RK; Tilley WD; Leedman PJ; Hurley DM
J Clin Endocrinol Metab; 1996 Jan; 81(1):236-43. PubMed ID: 8550758
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor defects in patients with minimal and partial androgen resistance classified according to a model of androgen-receptor complex energy states.
Kaufman M; Pinsky L; Gottlieb B; Schweitzer M; Brezezinski A; von Westarp C; Ginsberg J
Horm Res; 1990; 33(2-4):87-94. PubMed ID: 2210624
[TBL] [Abstract][Full Text] [Related]
14. Characterization of mutant androgen receptors causing partial androgen insensitivity syndrome.
De Bellis A; Quigley CA; Marschke KB; el-Awady MK; Lane MV; Smith EP; Sar M; Wilson EM; French FS
J Clin Endocrinol Metab; 1994 Mar; 78(3):513-22. PubMed ID: 8126121
[TBL] [Abstract][Full Text] [Related]
15. A G577R mutation in the human AR P box results in selective decreases in DNA binding and in partial androgen insensitivity syndrome.
Nguyen D; Steinberg SV; Rouault E; Chagnon S; Gottlieb B; Pinsky L; Trifiro M; Mader S
Mol Endocrinol; 2001 Oct; 15(10):1790-802. PubMed ID: 11579211
[TBL] [Abstract][Full Text] [Related]
16. Novel amino acid substitutional mutation, tyrosine-739-aspartic acid, in the androgen receptor gene in complete androgen insensitivity syndrome.
Suzuki K; Fukabori Y; Nakazato H; Hasumi M; Matsui H; Ito K; Kurokawa K; Yamanaka H
Int J Androl; 2001 Jun; 24(3):183-8. PubMed ID: 11380707
[TBL] [Abstract][Full Text] [Related]
17. Characterization of alternative amino acid substitutions at arginine 830 of the androgen receptor that cause complete androgen insensitivity in three families.
Shkolny DL; Brown TR; Punnett HH; Kaufman M; Trifiro MA; Pinsky L
Hum Mol Genet; 1995 Apr; 4(4):515-21. PubMed ID: 7633398
[TBL] [Abstract][Full Text] [Related]
18. Ligand-specific thermal misbehavior of synthetic androgen-receptor complexes in genital skin fibroblasts of subjects with familial ligand-sensitive androgen resistance.
Kaufman M; Pinsky L; Killinger DW
J Steroid Biochem; 1986 Sep; 25(3):323-31. PubMed ID: 3490601
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome.
Ahmed SF; Cheng A; Dovey L; Hawkins JR; Martin H; Rowland J; Shimura N; Tait AD; Hughes IA
J Clin Endocrinol Metab; 2000 Feb; 85(2):658-65. PubMed ID: 10690872
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of androgen insensitivity.
Brinkmann AO
Mol Cell Endocrinol; 2001 Jun; 179(1-2):105-9. PubMed ID: 11420135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
